The curse of Treatment Leisure’s existence has been that it’s a studio that may make beloved and critically acclaimed video games that sadly aren’t in a position to crack the highest of the gross sales charts.
That curse has slowly begun to interrupt since 2019’s Management, and now after final yr’s stellar launch of Alan Wake 2, issues are getting higher on a regular basis for Treatment.
Within the studio’s most up-to-date monetary report for 2024’s second quarter, it reported a income improve of 16% in comparison with final yr, and whereas Alan Wake 2 has nonetheless but to completely make again its growth prices, chief government officer Tero Virtala says that “on the time of publishing this report, Alan Wake 2 has recouped most of its growth and advertising bills.”
Again in April it was reported that Alan Wake 2 hadn’t but made its growth prices again since its launch late final yr. That hasn’t modified, nevertheless it’s clear from Virtala’s wording this time round that it’s a lot nearer, and it wouldn’t be stunning if by the following quarterly report, it has made again its prices and is formally bringing in earnings.
Within the meantime, Treatment goes to proceed specializing in what it must be specializing in – delivering video games on the high quality bar it all the time has, and increasing its “Treatment Related Universe” between Management and Alan Wake, particularly now that Treatment wholly owns these IP’s.
Supply – [Remedy Entertainment]